Clearmind Medicine Inc. (CMND) stock
CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$3.04−0.02 (-0.82%)
Close on Nov 19, 2026Market cap $480.55KP/E –Yield –
Clearmind Medicine free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2022 it was -$3.73M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Oct 31, 2022 | -$3.73M | – |
| FY2021 | Oct 31, 2021 | -$2.09M | – |
See a number that looks wrong?